Dr. Jan–Philipp Kruse

Dr. Jan–Philipp Kruse, Associate

Associate
Berlin, Germany

Email: jan-philipp.kruse@catenion.com





Jan–Philipp Kruse is an Associate with Catenion and lives in Berlin.

Jan–Philipp has worked on a number of strategic client engagements for several large and mid-size companies in the life sciences. His focus has been on market and product evaluation and forecasting, as well as on the various aspects of sales force organization.

Jan–Philipp holds a Ph.D. from Columbia University in New York, where he studied the regulation of p53, a major tumor suppressor. His work identified two novel regulatory pathways for this crucial biological molecule central to the understanding of tumorigenesis and has been published in top tier scientific journals. Prior to his graduate studies at Columbia University, Jan–Philipp studied Biochemistry at the University of Bristol, UK, and gained industry experience during a one year internship in the Bioprocess R&D Department at Merck & Co in New Jersey, USA. Prior to joining Catenion in May 2010, he has worked in the Management Consulting Team of IMS Health.

In his spare time, Jan–Philipp enjoys running and cycling, as well as music and film.